Microglia and neuroprotection: from in vitro studies to therapeutic applications
- PMID: 20609379
- DOI: 10.1016/j.pneurobio.2010.06.009
Microglia and neuroprotection: from in vitro studies to therapeutic applications
Abstract
Microglia are the main immune cells in the brain, playing a role in both physiological and pathological conditions. Microglial involvement in neurodegenerative diseases is well-established, being microglial activation and neuroinflammation common features of these neuropathologies. Microglial activation has been considered harmful for neurons, but inflammatory state is not only associated with neurotoxic consequences, but also with neuroprotective effects, such as phagocytosis of dead neurons and clearance of debris. This brought to the idea of protective autoimmunity in the brain and to devise immunomodulatory therapies, aimed to specifically increase neuroprotective aspects of microglia. During the last years, several data supported the intrinsic neuroprotective function of microglia through the release of neuroprotective molecules. These data led to change the traditional view of microglia in neurodegenerative diseases: from the idea that these cells play an detrimental role for neurons due to a gain of their inflammatory function, to the proposal of a loss of microglial neuroprotective function as a causing factor in neuropathologies. This "microglial dysfunction hypothesis" points at the importance of understanding the mechanisms of microglial-mediated neuroprotection to develop new therapies for neurodegenerative diseases. In vitro models are very important to clarify the basic mechanisms of microglial-mediated neuroprotection, mainly for the identification of potentially effective neuroprotective molecules, and to design new approaches in a gene therapy set-up. Microglia could act as both a target and a vehicle for CNS gene delivery of neuroprotective factors, endogenously produced by microglia in physiological conditions, thus strengthening the microglial neuroprotective phenotype, even in a pathological situation.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.J Pharmacol Exp Ther. 2003 Apr;305(1):212-8. doi: 10.1124/jpet.102.043166. J Pharmacol Exp Ther. 2003. PMID: 12649371
-
Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation.Brain Res Brain Res Rev. 2005 Apr;48(2):251-6. doi: 10.1016/j.brainresrev.2004.12.015. Epub 2005 Jan 18. Brain Res Brain Res Rev. 2005. PMID: 15850664 Review.
-
Neuronal injury in chronic CNS inflammation.Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Best Pract Res Clin Anaesthesiol. 2010. PMID: 21619866 Review.
-
Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.Life Sci. 2006 Dec 23;80(3):193-9. doi: 10.1016/j.lfs.2006.09.010. Epub 2006 Sep 20. Life Sci. 2006. PMID: 17049947
-
Microglia and neuroprotection: implications for Alzheimer's disease.Brain Res Brain Res Rev. 2005 Apr;48(2):234-9. doi: 10.1016/j.brainresrev.2004.12.013. Epub 2005 Jan 15. Brain Res Brain Res Rev. 2005. PMID: 15850662 Review.
Cited by
-
Bone marrow stromal cells-derived exosomes target DAB2IP to induce microglial cell autophagy, a new strategy for neural stem cell transplantation in brain injury.Exp Ther Med. 2020 Sep;20(3):2752-2764. doi: 10.3892/etm.2020.9008. Epub 2020 Jul 13. Exp Ther Med. 2020. PMID: 32765770 Free PMC article.
-
The role of microglia in the pathogenesis of diabetic-associated cognitive dysfunction.Front Endocrinol (Lausanne). 2024 Jan 11;14:1246979. doi: 10.3389/fendo.2023.1246979. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38274227 Free PMC article. No abstract available.
-
Activated microglia provide a neuroprotective role by balancing glial cell-line derived neurotrophic factor and tumor necrosis factor-α secretion after subacute cerebral ischemia.Int J Mol Med. 2013 Jan;31(1):172-8. doi: 10.3892/ijmm.2012.1179. Epub 2012 Nov 13. Int J Mol Med. 2013. PMID: 23151666 Free PMC article.
-
From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery-An Australian Example.Int J Mol Sci. 2023 Jul 4;24(13):11086. doi: 10.3390/ijms241311086. Int J Mol Sci. 2023. PMID: 37446262 Free PMC article. Review.
-
Microglia lacking a peroxisomal β-oxidation enzyme chronically alter their inflammatory profile without evoking neuronal and behavioral deficits.J Neuroinflammation. 2019 Mar 13;16(1):61. doi: 10.1186/s12974-019-1442-3. J Neuroinflammation. 2019. PMID: 30866963 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
